Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Updated Food Recall Warning - Imperial Caviar & Seafood brand Whitefish Roe recalled due to potential presence of dangerous bacteria


Product photos are available at http://bit.ly/2mWzidW

OTTAWA, Jan. 19, 2018 /CNW/ - The food recall warning issued on January 12, 2018 has been updated to include additional product information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation.

Imperial Caviar & Seafood is recalling Imperial Caviar & Seafood brand Whitefish Roe from the marketplace because it may permit the growth of Clostridium botulinum. Consumers should not consume the recalled product described below.

The following product has been sold in Quebec and Ontario and may have been distributed in other provinces or territories.

Recalled product

 

Brand

Product

Size

UPC

Codes

Imperial Caviar & Seafood

Whitefish Roe

50 g

1 86866 90027 9

Lot #: 14017-01

BB/MA: 29-MAI-2018

 

What you should do

If you think you became sick from consuming a recalled product, call your doctor.

Check to see if you have recalled products in your home. Recalled products should be thrown out or returned to the store where they were purchased.

Food contaminated with Clostridium botulinum toxin may not look or smell spoiled but can still make you sick.  Symptoms can include facial paralysis or loss of facial expression, unreactive or fixed pupils, difficulty swallowing, drooping eyelids, blurred or double vision, difficulty speaking or slurred speech, and a change in sound of voice, including hoarseness.

Background

This recall was triggered by the CFIA inspection activities. The CFIA is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing recalled product from the marketplace.

Illnesses

There have been no reported illnesses associated with the consumption of this product.

More information

 

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 13:17
Rexall is proud to unveil its first Pharmacist Care Walk-In Clinic in Barrie, Ontario on Friday, April 19. Located at 353 Duckworth Street, the clinic will offer personalized care to the community while providing immediate pharmacist treatment for...

at 13:13
Caring for communities extends beyond life-changing work in operating rooms and physician offices. Hartford HealthCare leadership today highlighted its corporate responsibility to environmental, social and economic sustainability in announcing its...

at 13:04
Concept Medical, a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical study, "MAGICAL-ISR" using MagicTouch ? Sirolimus drug coated balloon (DCB), for the management of in-stent...

at 12:30
The American College of Physicians (ACP) today released an update of its 2017 guideline with clinical recommendations for the use of newer pharmacological treatments of adults with Type 2 diabetes. The clinical guideline is based on the best...

at 12:10
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...

at 12:00
Maintaining asthma medication and asthma control leads to safer perinatal outcomes for pregnant women according to new research published in The Journal of Allergy and Clinical Immunology: In Practice (JACI: In Practice), an official journal of the...



News published on and distributed by: